NCT01961882View on ClinicalTrials.gov

A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 16, 2017

Study Completion Date

November 16, 2017

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

OCV-501

DRUG

Placebo

Trial Locations (14)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Daegu

Seoul

Kaoshiung

Taichung

Tainan City

Taipei

Sponsors
All Listed Sponsors
collaborator

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

NCT01961882 - A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter